SEC Company Response from Main Street Capital (MAIN) — Apr 27, 2018
Main Street Capital CORP
Date: April 27, 2018 · CIK: 0001396440 · Accession: 0001104659-18-027795
AI Filing Summary & Sentiment
File numbers found in text: 333-223483
Letter
Via EDGAR U.S. Securities and Exchange Commission Division of Investment Management — Disclosure Review Office 100 F Street N.E. Washington, D.C. 20549 RE: Main Street Capital Corporation — Registration Statement on Form N-2 (File No. 333-223483) (the “Registration Statement”)
Dear Ms. Fettig and Ms. Rossotto:
On behalf of Main Street Capital Corporation (the “Company”), set forth below are the Company’s responses to the comments provided orally by the staff of the Division of Investment Management (the “Staff”) of the Securities and Exchange Commission (the “SEC”) to the Company on March 28, 2018, April 6, 2018 and April 23, 2018 relating to the Registration Statement. The Staff’s comments are set forth below and are followed by the Company’s responses. Where revisions to the Registration Statement are referenced in the Company’s responses set forth below, such revisions have been included in Pre-Effective Amendment No. 1 to the Registration Statement and the prospectus included therein (the “Prospectus”).
Accounting Comments
General
1. If more than 30 days has passed since the initial filing of the Registration Statement, please include an updated consent from the Company’s auditor with the filing of Pre-Effective Amendment No. 1 to the Registration Statement.
Response: The Company acknowledges the Staff’s comment and has included an updated consent from its auditor as an exhibit to Pre-Effective Amendment No.1 to the Registration Statement.
Eversheds Sutherland (US) LLP is part of a global legal practice, operating through various separate and distinct legal entities, under Eversheds Sutherland. For a full description of the structure and a list of offices, please visit www.eversheds-sutherland.com.
Christina DiAngelo Fettig
Karen Rossotto
April 27, 2018
Page 2
2. Please include the Company’s most recent quarterly financial statements in the Registration Statement if such information becomes available prior to the Registration Statement being declared effective.
Response: The Company acknowledges the Staff’s comments and will include the most recent available financial information in the Registration Statement at the time it is declared effective.
3. Please confirm that if the Company’s Registration Statement is not declared effective prior to the date on which its audited finical statements must be updated pursuant to Section 10(a)(3) of the Securities Act of 1933, the Company will not make any sales of securities under the Registration Statement until it has been declared effective by the Staff.
Response: The Company confirms that no sales of securities will be made pursuant to the Registration Statement after April 30, 2018 unless a post-effective amendment thereto containing its December 31, 2017 audited financial statements has been declared effective by the Staff.
4. The Staff notes that the Company’s disclosure indicates that it is a non-diversified investment company, but it appears that the Company may be operating as a “diversified company” as such term is defined in the 1940 Act. Please consider whether any changes to the disclosure are necessary.
Response: The Company acknowledges the Staff’s comment and advises the Staff that the Company currently does not and does not intend in the future to operate as a “diversified company” as such term is defined in the 1940 Act. In this regard, the Company does not currently fall within the definition of a diversified company because greater than 25 percent of its total assets are invested in the securities of issuers of which the Company holds more than 10 percent of the outstanding voting securities of such issuer. Further, the Company has not operated as a diversified company in any of the prior three years. While the Company’s portfolio composition may in certain periods fall within the requirements of a diversified company, the Company believes that its current disclosure accurately describes how the Company manages its portfolio.
Consolidated Statement of Operations
5. Please revise the line item for net change in unrealized appreciation (depreciation) on portfolio investments to state separately the net change in unrealized appreciation (depreciation) for control investments, affiliate investment and non-control/non-affiliate investments. See Regulation S-X Rule 6-07.7(c).
Response: Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will revise its presentation on the consolidated statement of operations to separately state the net change in unrealized appreciation (depreciation) for control investments, affiliate investments and non-control/non-affiliate investments.
Christina DiAngelo Fettig
Karen Rossotto
April 27, 2018
Page 3
6. If there are any individual expenses included in the line item titled “General and Administrative Expenses” that represent more than 5% of total expenses included in this caption, please disclose such expenses separately in accordance with Regulation S-X, Article 6-07.2(b).
Response: The Company confirms that all individual expense items that are greater than 5% of total expenses are broken out on the face of consolidated statements of operations.
Consolidated Schedule of Investments
7. In Note 1, Valuation of the Investment Portfolio, to the Company’s Consolidated Financial Statements the disclosure notes that the Company’s portfolio investments may be subject to restrictions on resale. Please indicate which securities listed in the Company’s Consolidated Schedule of Investments are restricted and include the disclosures required by footnote 8 to Rule 12-12 of Regulation S-X. In addition, please ensure that subtotals for each category of investments are shown together with their percentage value compared to net assets as required by footnote 5 to Rule 12-12.
Response: The Company advises the Staff that in order to continue to qualify as a business development company, or BDC, the Company will generally invest in securities purchased in private transactions from private issuers. As a result, the Company’s investments will generally be subject to limitations on resale and therefore may be deemed to be “restricted securities” under the Securities Act and the rules thereunder. Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will include the disclosure required by footnote 8 to Rule 12-12 to the extent such disclosures are applicable.
Additionally, beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will ensure that subtotals for each category of investments are shown together with their percentage value compared to the Company’s net assets.
Consolidated Schedule of Investments in and Advances to Affiliates
8. Please include the information required by Column B of the table required by Rule 12-14.
Response: The Company respectfully advises the Staff that the information required by Column B related to number of shares, principal amount of bonds, notes and other indebtedness is included under “Type of Investment” in the consolidated schedule of investments for each issuer. The Company has categorized its consolidated schedule of investments such that its investments in affiliates are grouped together. In this manner, the Company believes that an investor may easily identify the information required by Column B of the table required by Rule 12-14 for each of the Company’s investments in affiliates. As a result, the Company believes that it has provided the information required by Column B of the table required by Rule 12-14 through its consolidated schedule of investments.
Christina DiAngelo Fettig
Karen Rossotto
April 27, 2018
Page 4
9. Please ensure that the portfolio company descriptions in the Schedule of Investments in and Advances to Affiliates are consistent with the portfolio company descriptions in the Schedule of Investments.
Response: The Company acknowledges the Staff’s comment and will ensure that the portfolio company descriptions in the consolidated schedule of investments in and advances to affiliates are consistent with the portfolio company descriptions in the consolidated schedule of investments going forward.
10. Please ensure that the disclosure requirements of all footnotes to Rule 12-14 are satisfied, particularly footnotes 3, 5, 6, 7 and 8 to Rule 12-14.
Response: The Company respectfully advises the Staff that it has categorized its consolidated schedule of investments such that its investments in affiliates are grouped together. In this manner, the Company believes that an investor may easily identify the information required by each footnote to the table required by Rule 12-14 for each of the Company’s investments in affiliates in the Company’s consolidated schedule of investments.
The Company respectfully advises the Staff that the information required by footnotes 3, 5, 6 and 8 is disclosed within the consolidated schedule of investments as follows:
Footnote 3: The related disclosures in footnote 3 regarding interest rate or preferential dividend rate and maturity date are included under “Type of Investment” column in the consolidated schedule of investments. Please also see footnote (9) within the consolidated schedule of investments regarding disclosures for variable rate securities.
Footnote 5: As noted in the Company’s response to comment 7 above, beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will include a footnote to its consolidated schedule of investments in and advances to affiliates to indicate that the Company’s portfolio investments are generally subject to restrictions on resale as “restricted securities”.
Footnote 6: The related subtotals for dividends or interest and realized gain or loss are currently included within the consolidated schedule of investments in and advances to affiliates. Symbols regarding non-cash dividends and interest, non-income producing securities, are disclosed under footnotes (14) and (19) of the consolidated schedule of investments.
Footnote 8: The related disclosures in footnote 8 are disclosed under (18) of the consolidated schedule of investments.
Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will include subtotals of investments relating to their respective geographies within the consolidated schedule of investments in and advances to affiliates to satisfy footnote 7.
Christina DiAngelo Fettig
Karen Rossotto
April 27, 2018
Page 5
11. Please ensure that the total for the column disclosing the amount of unrealized gain/(loss) ties back to the amount of change in unrealized appreciation/(depreciation) indicated in the Statement of Operations for the Company’s control and affiliate investments.
Response: Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will ensure the total of unrealized gain/(loss) agrees to the consolidated statement of operations for the Company’s control and affiliate investments.
Legal Comments
Prospectus Summary
1. The Staff notes the bullet point under the heading “Risk Factors” that refers to significant potential conflicts of interest which could impact investment returns. Please disclose each potential conflict of interest in a separate risk factor.
Response: The Company respectfully advises the Staff that the significant potential conflicts of interest which could impact investment returns are the conflicts it may face in allocating investment opportunities between the Company and HMS Income that are described in detail in the Risk Factor titled “There are significant potential conflicts of interest which could impact our investment returns” on page 18 of the Prospectus.
2. The Staff notes the bullet point under the heading “Risk Factors” that refers to the Company’s exposure through its investments to blockchain and/or cryptocurrency. Is the use of blockchain and/or cryptocurrency a principal strategy of the Company? Does the Company intend to invest directly, or indirectly through bitcoin derivatives, in cryptocurrency? The Staff notes that the risk disclosure included on page 6 of the Prospectus appears to indicate that these risks may impact the Company directly. Please advise.
Response: The Company respectfully advises the Staff that the use of blockchain and/or cryptocurrency is not a principal strategy of the Company. The Company further advises the Staff that it does not hold any cryptocurrency or cryptocurrency derivatives and does not intend to invest directly, or indirectly through bitcoin derivatives, in cryptocurrency.
The Company respectfully advises the Staff that the risk factor referred to in the Staff’s comment relates to the Company’s portfolio companies and not the Company itself. In particular, the Company is aware that one of its portfolio companies, as a non-primary aspect of its business, has a subsidiary that has mined cryptocurrency. However, the Company is not currently invested in any portfolio company that utilizes blockchain or cryptocurrency as the primary aspect of it business, nor will it invest in any such portfolio companies without further guidance from the Staff.
After reviewing this disclosure and considering the factors described above, the Company advises the Staff that it will remove the disclosure referred to in the Staff’s comment from the Prospectus.
Christina DiAngelo Fettig
Karen Rossotto
April 27, 2018
Page 6
3. With respect to the response to comment 2 above, to the extent one of the Company’s portfolio companies has mined cryptocurrency, is the risk related to the cryptocurrency assets it continues to hold, or is it related to the portfolio company’s subsidiary’s business, which is mining cryptocurrency?
Response: The Company respectfully advises the Staff that, as noted in its response to comment 2 above, the Company is only aware of one portfolio company that has, as a non-primary aspect of its business, mined cryptocurrency through a subsidiary. The Company advises the Staff that although this is not the portfolio company’s primary business, the Company believes that its investment in this portfolio company may indirectly expose it to risks because (i) the portfolio company may hold cryptocurrency assets and (ii) because it utilizes potentially vulnerable technology in its mining of cryptocurrency.
4. If the Company’s response to Comment No. 2 above is that the Company does not intend to invest directly, or indirectly through bitcoin derivatives, in cryptocurrency, please revise the prospectus to prominently disclose that the Company will not invest directly, or indirectly through bitcoin derivatives, in cryptocurrency.
Response: The Company respectfully advises the Staff that it does not believe that prominent disclosure of a statement to this effect would be appropriate. The Company believes that such disclosure would be equivalent to a negative strategy, which the SEC’s securities registration forms do not permit other registrants to disclose (see, Form N-1A, Item 9(b)(1), instruction 3). Such disclosure would be inconsistent with the practice of statin
Show Raw Text
CORRESP 1 filename1.htm Eversheds Sutherland (US) LLP 700 Sixth Street, NW, Suite 700 Washington, DC 20001-3980 D: +1 202.383.0805 F: +1 202.637.3593 harrypangas@ eversheds-sutherland.com April 27, 2018 Via EDGAR Ms. Christina DiAngelo Fettig Senior Staff Accountant U.S. Securities and Exchange Commission Division of Investment Management — Disclosure Review Office 100 F Street N.E. Washington, D.C. 20549 Ms. Karen Rossotto Senior Counsel U.S. Securities and Exchange Commission Division of Investment Management — Disclosure Review Office 100 F Street N.E. Washington, D.C. 20549 RE: Main Street Capital Corporation — Registration Statement on Form N-2 (File No. 333-223483) (the “Registration Statement”) Dear Ms. Fettig and Ms. Rossotto: On behalf of Main Street Capital Corporation (the “Company”), set forth below are the Company’s responses to the comments provided orally by the staff of the Division of Investment Management (the “Staff”) of the Securities and Exchange Commission (the “SEC”) to the Company on March 28, 2018, April 6, 2018 and April 23, 2018 relating to the Registration Statement. The Staff’s comments are set forth below and are followed by the Company’s responses. Where revisions to the Registration Statement are referenced in the Company’s responses set forth below, such revisions have been included in Pre-Effective Amendment No. 1 to the Registration Statement and the prospectus included therein (the “Prospectus”). Accounting Comments General 1. If more than 30 days has passed since the initial filing of the Registration Statement, please include an updated consent from the Company’s auditor with the filing of Pre-Effective Amendment No. 1 to the Registration Statement. Response: The Company acknowledges the Staff’s comment and has included an updated consent from its auditor as an exhibit to Pre-Effective Amendment No.1 to the Registration Statement. Eversheds Sutherland (US) LLP is part of a global legal practice, operating through various separate and distinct legal entities, under Eversheds Sutherland. For a full description of the structure and a list of offices, please visit www.eversheds-sutherland.com. Christina DiAngelo Fettig Karen Rossotto April 27, 2018 Page 2 2. Please include the Company’s most recent quarterly financial statements in the Registration Statement if such information becomes available prior to the Registration Statement being declared effective. Response: The Company acknowledges the Staff’s comments and will include the most recent available financial information in the Registration Statement at the time it is declared effective. 3. Please confirm that if the Company’s Registration Statement is not declared effective prior to the date on which its audited finical statements must be updated pursuant to Section 10(a)(3) of the Securities Act of 1933, the Company will not make any sales of securities under the Registration Statement until it has been declared effective by the Staff. Response: The Company confirms that no sales of securities will be made pursuant to the Registration Statement after April 30, 2018 unless a post-effective amendment thereto containing its December 31, 2017 audited financial statements has been declared effective by the Staff. 4. The Staff notes that the Company’s disclosure indicates that it is a non-diversified investment company, but it appears that the Company may be operating as a “diversified company” as such term is defined in the 1940 Act. Please consider whether any changes to the disclosure are necessary. Response: The Company acknowledges the Staff’s comment and advises the Staff that the Company currently does not and does not intend in the future to operate as a “diversified company” as such term is defined in the 1940 Act. In this regard, the Company does not currently fall within the definition of a diversified company because greater than 25 percent of its total assets are invested in the securities of issuers of which the Company holds more than 10 percent of the outstanding voting securities of such issuer. Further, the Company has not operated as a diversified company in any of the prior three years. While the Company’s portfolio composition may in certain periods fall within the requirements of a diversified company, the Company believes that its current disclosure accurately describes how the Company manages its portfolio. Consolidated Statement of Operations 5. Please revise the line item for net change in unrealized appreciation (depreciation) on portfolio investments to state separately the net change in unrealized appreciation (depreciation) for control investments, affiliate investment and non-control/non-affiliate investments. See Regulation S-X Rule 6-07.7(c). Response: Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will revise its presentation on the consolidated statement of operations to separately state the net change in unrealized appreciation (depreciation) for control investments, affiliate investments and non-control/non-affiliate investments. Christina DiAngelo Fettig Karen Rossotto April 27, 2018 Page 3 6. If there are any individual expenses included in the line item titled “General and Administrative Expenses” that represent more than 5% of total expenses included in this caption, please disclose such expenses separately in accordance with Regulation S-X, Article 6-07.2(b). Response: The Company confirms that all individual expense items that are greater than 5% of total expenses are broken out on the face of consolidated statements of operations. Consolidated Schedule of Investments 7. In Note 1, Valuation of the Investment Portfolio, to the Company’s Consolidated Financial Statements the disclosure notes that the Company’s portfolio investments may be subject to restrictions on resale. Please indicate which securities listed in the Company’s Consolidated Schedule of Investments are restricted and include the disclosures required by footnote 8 to Rule 12-12 of Regulation S-X. In addition, please ensure that subtotals for each category of investments are shown together with their percentage value compared to net assets as required by footnote 5 to Rule 12-12. Response: The Company advises the Staff that in order to continue to qualify as a business development company, or BDC, the Company will generally invest in securities purchased in private transactions from private issuers. As a result, the Company’s investments will generally be subject to limitations on resale and therefore may be deemed to be “restricted securities” under the Securities Act and the rules thereunder. Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will include the disclosure required by footnote 8 to Rule 12-12 to the extent such disclosures are applicable. Additionally, beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will ensure that subtotals for each category of investments are shown together with their percentage value compared to the Company’s net assets. Consolidated Schedule of Investments in and Advances to Affiliates 8. Please include the information required by Column B of the table required by Rule 12-14. Response: The Company respectfully advises the Staff that the information required by Column B related to number of shares, principal amount of bonds, notes and other indebtedness is included under “Type of Investment” in the consolidated schedule of investments for each issuer. The Company has categorized its consolidated schedule of investments such that its investments in affiliates are grouped together. In this manner, the Company believes that an investor may easily identify the information required by Column B of the table required by Rule 12-14 for each of the Company’s investments in affiliates. As a result, the Company believes that it has provided the information required by Column B of the table required by Rule 12-14 through its consolidated schedule of investments. Christina DiAngelo Fettig Karen Rossotto April 27, 2018 Page 4 9. Please ensure that the portfolio company descriptions in the Schedule of Investments in and Advances to Affiliates are consistent with the portfolio company descriptions in the Schedule of Investments. Response: The Company acknowledges the Staff’s comment and will ensure that the portfolio company descriptions in the consolidated schedule of investments in and advances to affiliates are consistent with the portfolio company descriptions in the consolidated schedule of investments going forward. 10. Please ensure that the disclosure requirements of all footnotes to Rule 12-14 are satisfied, particularly footnotes 3, 5, 6, 7 and 8 to Rule 12-14. Response: The Company respectfully advises the Staff that it has categorized its consolidated schedule of investments such that its investments in affiliates are grouped together. In this manner, the Company believes that an investor may easily identify the information required by each footnote to the table required by Rule 12-14 for each of the Company’s investments in affiliates in the Company’s consolidated schedule of investments. The Company respectfully advises the Staff that the information required by footnotes 3, 5, 6 and 8 is disclosed within the consolidated schedule of investments as follows: Footnote 3: The related disclosures in footnote 3 regarding interest rate or preferential dividend rate and maturity date are included under “Type of Investment” column in the consolidated schedule of investments. Please also see footnote (9) within the consolidated schedule of investments regarding disclosures for variable rate securities. Footnote 5: As noted in the Company’s response to comment 7 above, beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will include a footnote to its consolidated schedule of investments in and advances to affiliates to indicate that the Company’s portfolio investments are generally subject to restrictions on resale as “restricted securities”. Footnote 6: The related subtotals for dividends or interest and realized gain or loss are currently included within the consolidated schedule of investments in and advances to affiliates. Symbols regarding non-cash dividends and interest, non-income producing securities, are disclosed under footnotes (14) and (19) of the consolidated schedule of investments. Footnote 8: The related disclosures in footnote 8 are disclosed under (18) of the consolidated schedule of investments. Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will include subtotals of investments relating to their respective geographies within the consolidated schedule of investments in and advances to affiliates to satisfy footnote 7. Christina DiAngelo Fettig Karen Rossotto April 27, 2018 Page 5 11. Please ensure that the total for the column disclosing the amount of unrealized gain/(loss) ties back to the amount of change in unrealized appreciation/(depreciation) indicated in the Statement of Operations for the Company’s control and affiliate investments. Response: Beginning with the Company’s quarterly report on Form 10-Q for the quarter ending June 30, 2018, the Company will ensure the total of unrealized gain/(loss) agrees to the consolidated statement of operations for the Company’s control and affiliate investments. Legal Comments Prospectus Summary 1. The Staff notes the bullet point under the heading “Risk Factors” that refers to significant potential conflicts of interest which could impact investment returns. Please disclose each potential conflict of interest in a separate risk factor. Response: The Company respectfully advises the Staff that the significant potential conflicts of interest which could impact investment returns are the conflicts it may face in allocating investment opportunities between the Company and HMS Income that are described in detail in the Risk Factor titled “There are significant potential conflicts of interest which could impact our investment returns” on page 18 of the Prospectus. 2. The Staff notes the bullet point under the heading “Risk Factors” that refers to the Company’s exposure through its investments to blockchain and/or cryptocurrency. Is the use of blockchain and/or cryptocurrency a principal strategy of the Company? Does the Company intend to invest directly, or indirectly through bitcoin derivatives, in cryptocurrency? The Staff notes that the risk disclosure included on page 6 of the Prospectus appears to indicate that these risks may impact the Company directly. Please advise. Response: The Company respectfully advises the Staff that the use of blockchain and/or cryptocurrency is not a principal strategy of the Company. The Company further advises the Staff that it does not hold any cryptocurrency or cryptocurrency derivatives and does not intend to invest directly, or indirectly through bitcoin derivatives, in cryptocurrency. The Company respectfully advises the Staff that the risk factor referred to in the Staff’s comment relates to the Company’s portfolio companies and not the Company itself. In particular, the Company is aware that one of its portfolio companies, as a non-primary aspect of its business, has a subsidiary that has mined cryptocurrency. However, the Company is not currently invested in any portfolio company that utilizes blockchain or cryptocurrency as the primary aspect of it business, nor will it invest in any such portfolio companies without further guidance from the Staff. After reviewing this disclosure and considering the factors described above, the Company advises the Staff that it will remove the disclosure referred to in the Staff’s comment from the Prospectus. Christina DiAngelo Fettig Karen Rossotto April 27, 2018 Page 6 3. With respect to the response to comment 2 above, to the extent one of the Company’s portfolio companies has mined cryptocurrency, is the risk related to the cryptocurrency assets it continues to hold, or is it related to the portfolio company’s subsidiary’s business, which is mining cryptocurrency? Response: The Company respectfully advises the Staff that, as noted in its response to comment 2 above, the Company is only aware of one portfolio company that has, as a non-primary aspect of its business, mined cryptocurrency through a subsidiary. The Company advises the Staff that although this is not the portfolio company’s primary business, the Company believes that its investment in this portfolio company may indirectly expose it to risks because (i) the portfolio company may hold cryptocurrency assets and (ii) because it utilizes potentially vulnerable technology in its mining of cryptocurrency. 4. If the Company’s response to Comment No. 2 above is that the Company does not intend to invest directly, or indirectly through bitcoin derivatives, in cryptocurrency, please revise the prospectus to prominently disclose that the Company will not invest directly, or indirectly through bitcoin derivatives, in cryptocurrency. Response: The Company respectfully advises the Staff that it does not believe that prominent disclosure of a statement to this effect would be appropriate. The Company believes that such disclosure would be equivalent to a negative strategy, which the SEC’s securities registration forms do not permit other registrants to disclose (see, Form N-1A, Item 9(b)(1), instruction 3). Such disclosure would be inconsistent with the practice of statin